Henry Ji, Sorrento CEO
February 18, 2022 10:42 AM EST
Pharma
Manufacturing

To keep up with de­mand, Sor­ren­to ac­quires ma­jor­i­ty own­er­ship in Covid-19 test man­u­fac­tur­er

Josh Sullivan

In a move that the com­pa­ny hopes will up its abil­i­ty to re­spond to de­mand for its Covid-19 tests, Sor­ren­to Ther­a­peu­tics has

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Au­toim­mune CAR-T da­ta dump: Kyver­na, Ca­balet­ta shares fall af­ter un­veil­ing ear­ly-stage re­sults

Gilead can­cer drug ma­grolimab showed wor­ry­ing trends around death

Up­dat­ed: Telix Phar­ma­ceu­ti­cals pulls Nas­daq list­ing plans just be­fore trad­ing was to start

Stephen Squin­to talks writ­ing checks and next-gen obe­si­ty drugs as JP Mor­gan clos­es first $500M+ biotech fund

Nurix’s pro­tein de­grad­er over­comes re­sis­tance to BTK mu­ta­tions in small leukemia study

sponsored

De-risk­ing the pa­tient jour­ney in cell ther­a­pies: Six key con­sid­er­a­tions

A service from the Financial Times